Vaxine Pty Ltd
16
2
3
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 16 trials
100.0%
+13.5% vs industry average
31%
5 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection
Role: lead
Autologous Tumour Vaccine Trial
Role: lead
Covid-19 and Influenza Oral Vaccine Study
Role: lead
Booster Study of SpikoGen COVID-19 Vaccine
Role: lead
A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)
Role: lead
Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine
Role: lead
Immunogenicity and Safety of a Booster Dose of the SpikoGen Vaccine in Kidney Transplant Recipients After Two Doses of Sinopharm Vaccine
Role: collaborator
Immunogenicity and Safety of the SpikoGen COVID-19 Vaccine in Children Aged 5 to <12 Years and 12 to <18 Years Compared With Adults Aged 18 to 40 Years
Role: collaborator
Immunogenicity and Safety of a Booster Dose of the SpikoGen COVID-19 Vaccine
Role: collaborator
Phase II Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)
Role: collaborator
Phase III Clinical Trial of CinnaGen COVID-19 Vaccine (SpikoGen)
Role: collaborator
Monovalent Recombinant COVID19 Vaccine
Role: lead
Study of Sting Challenge and Serological Responses to Jack Jumper Venom Immunotherapy With Inulin as Adjuvant (Jumpvax)
Role: collaborator
Recombinant H7 Hemagglutinin Influenza Vaccine Trial
Role: lead
Safety and Efficacy Study of Adjuvanted Prophylactic Hepatitis B Vaccine
Role: lead
A Phase 1 Study to Evaluate the Immunogenicity and Safety of a Pandemic Avian Influenza Vaccine in Adults
Role: lead
All 16 trials loaded